Search
Quantum BioPharma Ltd
QNTMAdd to Watchlist
3.510USD
+0.150+4.46%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
20.55MMarket Cap
LossP/E TTM
More Details of Quantum BioPharma Ltd Company
Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc., it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. The Company has also licensed unbuzzd, a formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of quickly relieving individuals from the effects of alcohol consumption. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.
Quantum BioPharma Ltd Info
Ticker SymbolQNTM
Company nameQuantum Biopharma Ltd
IPO dateMay 29, 2018
CEOKotra (Lakshmi P)
Number of employees- -
Security typeOrdinary Share
Fiscal year-endMay 29
Address55 University Ave. , Suite 1003
CityTORONTO
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryCanada
Postal codeM5J 2H7
Phone14168548884
Websitehttps://www.quantumbiopharma.com/
Ticker SymbolQNTM
IPO dateMay 29, 2018
CEOKotra (Lakshmi P)
Company Executives of Quantum BioPharma Ltd
Name
Name/Position
Position
Shareholding
Change
Mr. Zeeshan Saeed
Mr. Zeeshan Saeed
Executive Co-Chairman of the Board, President, Chief Executive Officer
Executive Co-Chairman of the Board, President, Chief Executive Officer
348.02K
+32.99%
Mr. Anthony Durkacz
Mr. Anthony Durkacz
Co-Executive Chairman of the Board
Co-Executive Chairman of the Board
258.72K
+44.37%
Mr. Donal Carroll, CPA
Mr. Donal Carroll, CPA
Chief Financial Officer
Chief Financial Officer
114.81K
-100.00%
Mr. Lawrence (Larry) Latowsky
Mr. Lawrence (Larry) Latowsky
Independent Director
Independent Director
--
--
Mr. Adnan Bashir
Mr. Adnan Bashir
Independent Director
Independent Director
--
--
Dr. Lakshmi P. Kotra, Ph.D.
Dr. Lakshmi P. Kotra, Ph.D.
Chief Executive Officer of Lucid, Director, President of FSD Biosciences and CEO of FSD Australia
Chief Executive Officer of Lucid, Director, President of FSD Biosciences and CEO of FSD Australia
--
--
Mr. Joseph L. Romano
Mr. Joseph L. Romano
Director
Director
--
--
Dr. Eric Hoskins, M.D.
Dr. Eric Hoskins, M.D.
Independent Director
Independent Director
--
--
Mr. Michael (Zappy) Zapolin
Mr. Michael (Zappy) Zapolin
Independent Director
Independent Director
--
--
Dr. Andrzej Chruscinski, M.D., Ph.D.
Dr. Andrzej Chruscinski, M.D., Ph.D.
Vice President - Clinical and Scientific Affairs
Vice President - Clinical and Scientific Affairs
--
-100.00%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Zeeshan Saeed
Mr. Zeeshan Saeed
Executive Co-Chairman of the Board, President, Chief Executive Officer
Executive Co-Chairman of the Board, President, Chief Executive Officer
348.02K
+32.99%
Mr. Anthony Durkacz
Mr. Anthony Durkacz
Co-Executive Chairman of the Board
Co-Executive Chairman of the Board
258.72K
+44.37%
Mr. Donal Carroll, CPA
Mr. Donal Carroll, CPA
Chief Financial Officer
Chief Financial Officer
114.81K
-100.00%
Mr. Lawrence (Larry) Latowsky
Mr. Lawrence (Larry) Latowsky
Independent Director
Independent Director
--
--
Mr. Adnan Bashir
Mr. Adnan Bashir
Independent Director
Independent Director
--
--
Dr. Lakshmi P. Kotra, Ph.D.
Dr. Lakshmi P. Kotra, Ph.D.
Chief Executive Officer of Lucid, Director, President of FSD Biosciences and CEO of FSD Australia
Chief Executive Officer of Lucid, Director, President of FSD Biosciences and CEO of FSD Australia
--
--
FAQs
Who are the top five shareholders of Quantum BioPharma Ltd?
The top five shareholders of Quantum BioPharma Ltd are: Mr. Zeeshan Saeed
How many institutions hold shares of Quantum BioPharma Ltd (QNTM)?
As of 2026Q1, 44 institutions hold shares of Quantum BioPharma Ltd, with a combined market value of approximately 568.64K, accounting for 8.89% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -641837.00.